Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2007 2
2008 4
2009 8
2010 10
2011 5
2012 3
2013 4
2014 11
2015 10
2016 11
2017 10
2018 8
2019 21
2020 16
2021 17
2022 15
2023 12
2024 14
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

162 results

Results by year

Filters applied: . Clear all
Page 1
Nelarabine, intensive L-asparaginase, and protracted intrathecal therapy for newly diagnosed T-cell acute lymphoblastic leukaemia in children and young adults (ALL-T11): a nationwide, multicenter, phase 2 trial including randomisation in the very high-risk group.
Sato A, Hatta Y, Imai C, Oshima K, Okamoto Y, Deguchi T, Hashii Y, Fukushima T, Hori T, Kiyokawa N, Kato M, Saito S, Anami K, Sakamoto T, Kosaka Y, Suenobu S, Imamura T, Kada A, Saito AM, Manabe A, Kiyoi H, Matsumura I, Koh K, Watanabe A, Miyazaki Y, Horibe K. Sato A, et al. Among authors: hashii y. Lancet Haematol. 2023 Jun;10(6):e419-e432. doi: 10.1016/S2352-3026(23)00072-8. Epub 2023 May 8. Lancet Haematol. 2023. PMID: 37167992 Clinical Trial.
JCCG ALL-B12: Evaluation of Intensified Therapies With Vincristine/Dexamethasone Pulses and Asparaginase and Augmented High-Dose Methotrexate for Pediatric B-ALL.
Kato M, Okamoto Y, Imamura T, Kada A, Saito AM, Iijima-Yamashita Y, Deguchi T, Ohki K, Fukushima T, Anami K, Sanada M, Taki T, Hashii Y, Inukai T, Kiyokawa N, Kosaka Y, Yoshida N, Yuza Y, Yanagimachi M, Watanabe K, Sato A, Imai C, Taga T, Adachi S, Horibe K, Manabe A, Koh K. Kato M, et al. Among authors: hashii y. J Clin Oncol. 2025 Feb 10;43(5):567-577. doi: 10.1200/JCO.24.00811. Epub 2024 Nov 12. J Clin Oncol. 2025. PMID: 39531610 Free PMC article. Clinical Trial.
Skeletal dysplasia in adenosine deaminase deficiency.
Minagawa H, Miyamura T, Hashii Y, Kanegane H, Ozono K. Minagawa H, et al. Among authors: hashii y. Pediatr Int. 2022 Jan;64(1):e15214. doi: 10.1111/ped.15214. Pediatr Int. 2022. PMID: 35791036 No abstract available.
Remdesivir and Human Milk: A Case Study.
Wada YS, Saito J, Hashii Y, Kishi T, Kobayashi M, Kamiya T, Mizuno K. Wada YS, et al. Among authors: hashii y. J Hum Lact. 2022 May;38(2):248-251. doi: 10.1177/08903344221076539. Epub 2022 Feb 21. J Hum Lact. 2022. PMID: 35189734 Clinical Trial.
Impact of center volume on outcomes in allogeneic hematopoietic cell transplantation for children.
Kato M, Nakashone H, Matsuo K, Ito Y, Yanagisawa A, Ohbiki M, Tabuchi K, Ichinohe T, Hashii Y, Kanda J, Goto H, Kato K, Yoshimitsu M, Sato A, Hino M, Matsumoto K, Yakushijin K, Atsuta Y, Fukuda T. Kato M, et al. Among authors: hashii y. Bone Marrow Transplant. 2025 Jun;60(6):851-856. doi: 10.1038/s41409-025-02569-3. Epub 2025 Apr 10. Bone Marrow Transplant. 2025. PMID: 40211066 Free PMC article.
Engraftment outcome of patients with anti-HLA antibodies in HLA-mismatched peripheral blood stem cell transplantation.
Hagino T, Ikegame K, Tanaka H, Kanda Y, Kaida K, Fukuda T, Kondo Y, Sato M, Doki N, Nakamae H, Matsuoka KI, Mori Y, Sano H, Eto T, Kawakita T, Hashii Y, Ichinohe T, Atsuta Y, Kanda J; HLA Working Group of Japanese Society for Transplantation, Cellular Therapy. Hagino T, et al. Among authors: hashii y. Int J Hematol. 2025 Jun;121(6):848-856. doi: 10.1007/s12185-025-03952-y. Epub 2025 Mar 20. Int J Hematol. 2025. PMID: 40113728 Free PMC article.
Differential impact of asparaginase discontinuation on outcomes of children with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
Ishida H, Imamura T, Kobayashi R, Hashii Y, Deguchi T, Miyamura T, Oda M, Yamamoto M, Okada K, Sano H, Koh K, Yuza Y, Watanabe K, Nishimura N, Takimoto T, Moriya-Saito A, Sekimizu M, Suenobu S, Sunami S, Horibe K. Ishida H, et al. Among authors: hashii y. Cancer Med. 2024 Jun;13(12):e7246. doi: 10.1002/cam4.7246. Cancer Med. 2024. PMID: 38888368 Free PMC article.
A Retrospective Study of Pediatric Patients With Low- or Intermediate-Risk Acute Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation for the AML-05 Study Conducted by the Japanese Pediatric Leukemia/Lymphoma Study Group.
Hashii Y, Kawaguchi K, Kurakami H, Umeda K, Hasegawa D, Taki T, Hyakuna N, Ishida H, Takahashi Y, Nagasawa M, Yabe H, Yano M, Nakazawa Y, Fujisaki H, Matsumoto K, Yanagimachi M, Yoshida N, Kakuda H, Satou A, Tabuchi K, Tomizawa D, Taga T, Adachi S, Koh K, Kato K. Hashii Y, et al. Transplant Cell Ther. 2024 Nov;30(11):1102.e1-1102.e12. doi: 10.1016/j.jtct.2024.08.011. Epub 2024 Aug 22. Transplant Cell Ther. 2024. PMID: 39181536 Free article.
Nationwide retrospective review of hematopoietic stem cell transplantation in children with refractory Langerhans cell histiocytosis.
Kudo K, Maeda M, Suzuki N, Kanegane H, Ohga S, Ishii E, Shioda Y, Imamura T, Imashuku S, Tsunematsu Y, Endo M, Shimada A, Koga Y, Hashii Y, Noguchi M, Inoue M, Tabuchi K, Morimoto A; Histiocytosis study group of the Japanese Society of Pediatric Hematology/Oncology. Kudo K, et al. Among authors: hashii y. Int J Hematol. 2020 Jan;111(1):137-148. doi: 10.1007/s12185-019-02760-5. Epub 2019 Nov 22. Int J Hematol. 2020. PMID: 31758416 Review.
162 results